These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7300343)

  • 1. Metabolism of the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione by male rhesus monkeys.
    Brodie AM; Romanoff LP; Williams KI
    J Steroid Biochem; 1981 Aug; 14(8):693-6. PubMed ID: 7300343
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.
    Brodie AM; Longcope C
    Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
    Covey DF; Hood WF
    Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956
    [No Abstract]   [Full Text] [Related]  

  • 5. Aromatase inhibitors III. Studies on the antifertility effect of 4-acetoxy-4-androstene-3,17-dione.
    Brodie AM; Wu JT; Marsh DA; Brodie HJ
    Biol Reprod; 1978 Apr; 18(3):365-70. PubMed ID: 566576
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
    Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM
    J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of 4-hydroxy-4-androstene-3,17-dione (4-OHA), a potent aromatase inhibitor, in human plasma, using isotope dilution mass spectrometry.
    Guarna A; Moneti G; Prucher D; Salerno R; Serio M
    J Steroid Biochem; 1989 May; 32(5):699-702. PubMed ID: 2739410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
    Snider CE; Brueggemeier RW
    J Steroid Biochem; 1985 Mar; 22(3):325-30. PubMed ID: 3990283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of deuterium- and tritium-labelled 4-hydroxyandrostene-3,17-dione, an aromatase inhibitor, and its metabolism in vitro and in vivo in the rat.
    Marsh DA; Romanoff L; Williams KI; Brodie HJ; Brodie AM
    Biochem Pharmacol; 1982 Mar; 31(5):701-5. PubMed ID: 7082338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
    Brodie AM; Marsh D; Brodie HJ
    J Steroid Biochem; 1979 Apr; 10(4):423-9. PubMed ID: 109701
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrogen biosynthesis and regression of mammary tumors by aromatase inhibitors.
    Brodie AM; Brodie HJ; Romanoff L; Williams JG; Williams KI; Wu JT
    Adv Exp Med Biol; 1981; 138():179-90. PubMed ID: 7342714
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibition and its pharmacologic implications.
    Brodie AM
    Biochem Pharmacol; 1985 Sep; 34(18):3213-9. PubMed ID: 3899122
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of recent development of aromatase inhibitors.
    Brodie AM
    Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and properties of the epimeric 6-hydroperoxyandrostenediones, new substrates/inhibitors of human placental aromatase.
    Tan L; Hrycay EG; Matsumoto K
    J Steroid Biochem; 1983 Sep; 19(3):1329-38. PubMed ID: 6621039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of 4-hydroxy-4-androstene-3,17-dione on androgen metabolism and action in cultured human foreskin fibroblasts.
    Hsiang YH; Berkovitz GD; Brown TR; Migeon CJ; Brodie AM
    J Steroid Biochem; 1987 Jan; 26(1):131-5. PubMed ID: 3821101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.